Enhancing the Objective Assessment of Friedreich Ataxia Severity: A Multiview IMU-Based Approach

Area of Science:

• Neuroscience
• Biomedical Engineering
• Clinical Neurology

Background:

• Friedreich's Ataxia (FRDA) is a progressive neurodegenerative disorder impacting motor control and balance.
• Current FRDA severity assessments are often fragmented, measuring domains separately.
• A unified, objective measure is needed for clinical trials and research.

Purpose of the Study:

• To introduce a novel multiview framework using inertial measurement unit (IMU) data for enhanced FRDA severity assessment.
• To develop a single, integrated score for quantifying disease progression.

Main Methods:

• Utilized data from three instrumented devices: Ataxia Instrumented Measures (AIMs) - cup (AIM-C), spoon (AIM-S), and pendent (AIM-P).
• Developed individual regression models and a multiview model integrating data from all three devices.
• Correlated the Aggregated IMU Multiview Score (AIM-M) with the modified Friedreich Ataxia Rating Scale (mFARS).

Main Results:

• Individual IMU devices showed moderate correlations with mFARS (0.749–0.83).
• The multiview model (AIM-M) achieved a significantly higher correlation (0.94) with mFARS.
• AIM-M demonstrated superior performance compared to single-view approaches.

Conclusions:

• Multiview IMU-based systems offer a sensitive and reliable method for assessing FRDA severity.
• The Aggregated IMU Multiview Score (AIM-M) provides a robust, scalable, and objective metric for FRDA.
• This approach enhances objective assessment in FRDA clinical research and trials.